Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/23/2021 07/26/2021 07/27/2021 07/28/2021 07/29/2021 Date
281.96(c) 286.26(c) 284(c) 313.45(c) 312.59(c) Last
4 456 557 4 025 303 4 318 824 4 880 646 4 059 643 Volume
+0.35% +1.53% -0.79% +10.37% -0.27% Change
More quotes
Estimated financial data (e)
Sales 2021 12 451 M 14 802 M 14 802 M
Net income 2021 7 102 M 8 443 M 8 443 M
Net cash position 2021 7 718 M 9 176 M 9 176 M
P/E ratio 2021 11,0x
Yield 2021 -
Sales 2022 10 730 M 12 756 M 12 756 M
Net income 2022 6 897 M 8 199 M 8 199 M
Net cash position 2022 13 225 M 15 722 M 15 722 M
P/E ratio 2022 12,3x
Yield 2022 -
Capitalization 75 497 M 75 497 M 89 751 M
EV / Sales 2021 5,44x
EV / Sales 2022 5,80x
Nbr of Employees 2 200
Free-Float 87,3%
More Financials
Company
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer... 
More about the company
Ratings of BioNTech SE
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about BIONTECH SE
05:32pPFIZER : Israel to give Pfizer COVID-19 booster to 60 and over as Delta spreads
AQ
04:42pPFIZER : Israel to offer 3rd COVID booster shot to older citizens
AQ
06:15aEUROPEAN MIDDAY BRIEFING : Stocks Rise as -2-
DJ
12:22aEMEA MORNING BRIEFING : Stocks to Open Lower After -2-
DJ
07/28MODERNA : Pfizer says 2021 COVID-19 vaccine sales to top $33.5 billion, sees nee..
RE
07/28STREET COLOR : Efficacy of Pfizer/BioNTech COVID-19 Vaccine Falls to 84% From 96..
MT
07/28GLOBAL MARKETS LIVE : Apple, Alphabet, Facebook, Pfizer, McDonald's...
07/28PFIZER : Reports Higher Second-Quarter Results as COVID-19 Vaccine Gives Boost, ..
MT
07/28Today on Wall Street: Better-than-expected earnings ahead of the Fed
07/28PFIZER : hikes Covid vaccine sales forecast by almost a third to $33.5bn
AQ
07/28PFIZER : Lifts 2021 Guidance For COVID-19 Vaccine Sales
MT
07/28Legal wrangles hold up U.S. vaccine donations to India
RE
07/27BIONTECH : AC Immune to Acquire Affiris' Vaccine Candidate Portfolio, Gets New I..
MT
07/27Health Care Climbs On Strong Earnings -- Health Care Roundup
DJ
07/27Global markets live: LVMH, Michelin, Tesla, Amazon, Activision...
More news
News in other languages on BIONTECH SE
03:33pIsrael will über 60-Jährigen dritte Corona-Impfung geben
07:50aBörse Stuttgart-News: Euwax Trends
04:22aISRAEL : áGrüner Pass soll steigende Corona-Zahlen bremsen
07/28Mega-Umsatz für Pfizer - US-Konzern hebt Prognose für Covid-Impfstoff an
07/28L'argent coule à flots pour Pfizer grâce à son sérum contre le Covid-19
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | BNTX | US09075V1026 | MarketScreener
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 312,59 €
Average target price 155,21 €
Spread / Average Target -50,3%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Ízlem TŘreci Chief Medical Officer
Sierk P÷tting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE284.51%75 705
GILEAD SCIENCES, INC.20.25%87 868
WUXI APPTEC CO., LTD.38.94%68 994
REGENERON PHARMACEUTICALS21.38%60 726
VERTEX PHARMACEUTICALS-14.43%52 353
GENMAB A/S13.76%29 077